Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
토요일, 9월 05

Usana Health Sciences Inc

USNANYSE
Trade with Public
Trade with Public
$14.96
0.533.67%
가까이에: Sep 4, 5:00 PM EST
$14.96
N/A
시간외: Sep 4, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Usana Health Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Usana Health Sciences (USNA).

Price Target Range — 6 Quarters

Analyst Consensus — 1 Analysts

1Hold
Consensus RatingNeutral# Analysts1Avg. Consensus PT$36Upside to Avg. PT+140.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Feb 27, 2025DA DavidsonLinda Bolton WeiserPT CutNeutral$38→$36
Jan 2, 2025DA DavidsonLinda Bolton WeiserPT RaiseNeutral$35→$38
More with Benzinga EdgeGet Access

Analyst Ratings News

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Friday after closing lower on Thursday’s. Futures of major benchmark indices were higher.
Rishabh Mishra

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $36.
Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $35 to $38.
Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $35.
Benzinga Newsdesk

Xencor Surges 10.5%: Is This an Indication of Further Gains?

Xencor (NASDAQ: XNCR) shares rallied 10.5% in the last trading session to close at $21.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 19.8% gain over the past four weeks.
Zacks

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $46 to $38.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved